{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:59:20Z","timestamp":1770411560321,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,21]],"date-time":"2010-03-21T00:00:00Z","timestamp":1269129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12253-010-9256-8","type":"journal-article","created":{"date-parts":[[2010,3,20]],"date-time":"2010-03-20T16:58:04Z","timestamp":1269104284000},"page":"547-551","source":"Crossref","is-referenced-by-count":30,"title":["Increased CTLA-4 and FOXP3 Transcripts in Peripheral Blood Mononuclear Cells of Patients with Breast Cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Mansooreh","family":"Jaberipour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Habibagahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saadat Rezai","family":"Habibabad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdolrasoul","family":"Talei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Ghaderi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,21]]},"reference":[{"key":"9256_CR1","first-page":"505","volume":"145","author":"L Kaklamanis","year":"1994","unstructured":"Kaklamanis L, Townsend A, Doussis-Anagnostopoulou IA et al (1994) Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am J Pathol 145:505\u2013509","journal-title":"Am J Pathol"},{"key":"9256_CR2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jlb.64.3.275","volume":"64","author":"KD Elgert","year":"1998","unstructured":"Elgert KD, Alleva DG, Mullins DW (1998) Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol 64:275\u2013290","journal-title":"J Leukoc Biol"},{"key":"9256_CR3","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1073\/pnas.95.3.1178","volume":"95","author":"K Staveley-O\u2019Carroll","year":"1998","unstructured":"Staveley-O\u2019Carroll K, Sotomayor E, Montgomery J et al (1998) Induction of antigen-specific T cell anergy: an early event in the course of tumor progression. Proc Natl Acad Sci USA 95:1178\u20131183","journal-title":"Proc Natl Acad Sci USA"},{"key":"9256_CR4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/0470871628.ch9","volume":"252","author":"MG Roncarolo","year":"2003","unstructured":"Roncarolo MG, Gregori S, Levings M (2003) Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells. Novartis Found Symp 252:115\u2013127","journal-title":"Novartis Found Symp"},{"key":"9256_CR5","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s00262-004-0556-2","volume":"53","author":"I Caras","year":"2004","unstructured":"Caras I, Grigorescu A, Stavaru C et al (2004) Evidence for immune defects in breast and lung cancer patients. Cancer Immunol Immunother 53:1146\u20131152","journal-title":"Cancer Immunol Immunother"},{"key":"9256_CR6","first-page":"606","volume":"9","author":"AM Wolf","year":"2003","unstructured":"Wolf AM, Wolf D, Steurer M et al (2003) Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 9:606\u2013612","journal-title":"Clin Cancer Res"},{"key":"9256_CR7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm0804-801","volume":"10","author":"A O\u2019Garra","year":"2004","unstructured":"O\u2019Garra A, Vieira P (2004) Regulatory T cells and mechanisms of immune system control. Nat Med 10:801\u2013805","journal-title":"Nat Med"},{"key":"9256_CR8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","volume":"101","author":"S Sakaguchi","year":"2000","unstructured":"Sakaguchi S (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455\u2013458","journal-title":"Cell"},{"key":"9256_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","volume":"6","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345\u2013352","journal-title":"Nat Immunol"},{"key":"9256_CR10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057\u20131061","journal-title":"Science"},{"key":"9256_CR11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.immuni.2005.01.016","volume":"22","author":"JD Fontenot","year":"2005","unstructured":"Fontenot JD, Rasmussen JP, Williams LM et al (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329\u2013341","journal-title":"Immunity"},{"key":"9256_CR12","first-page":"4766","volume":"61","author":"EY Woo","year":"2001","unstructured":"Woo EY, Chu CS, Goletz TJ et al (2001) Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 61:4766\u20134772","journal-title":"Cancer Res"},{"key":"9256_CR13","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.169.5.2756","volume":"169","author":"UK Liyanage","year":"2002","unstructured":"Liyanage UK, Moore TT, Joo HG et al (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169:2756\u20132761","journal-title":"J Immunol"},{"key":"9256_CR14","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.4049\/jimmunol.173.2.1444","volume":"173","author":"M Viguier","year":"2004","unstructured":"Viguier M, Lemaitre F, Verola O et al (2004) Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173:1444\u20131453","journal-title":"J Immunol"},{"key":"9256_CR15","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-04-3232","volume":"65","author":"LA Ormandy","year":"2005","unstructured":"Ormandy LA, Hillemann T, Wedemeyer H et al (2005) Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 65:2457\u20132464","journal-title":"Cancer Res"},{"key":"9256_CR16","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1371\/journal.pone.0000129","volume":"1","author":"SL Clarke","year":"2006","unstructured":"Clarke SL, Betts GJ, Plant A et al (2006) CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoSONE 1:e129","journal-title":"PLoS.ONE"},{"key":"9256_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2567.2007.02748.x","volume":"123","author":"A Gallimore","year":"2008","unstructured":"Gallimore A, Godkin A (2008) Regulatory T cells and tumour immunity\u2014observations in mice and men. Immunology 123:157\u2013163","journal-title":"Immunology"},{"key":"9256_CR18","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1158\/1078-0432.CCR-07-1403","volume":"13","author":"L Strauss","year":"2007","unstructured":"Strauss L, Bergmann C, Gooding W et al (2007) The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 13:6301\u20136311","journal-title":"Clin Cancer Res"},{"key":"9256_CR19","first-page":"749","volume":"30","author":"Y Bi","year":"2008","unstructured":"Bi Y, Wei L, Mao HT, Zhang L, Zuo WS (2008) Expressions of Fas, CTLA-4 and RhoBTB2 genes in breast carcinoma and their relationship with clinicopathological factors. Zhonghua ZhongLiu Za Zhi 30:749\u2013753, Article in Chinease","journal-title":"Zhonghua Zhong.Liu Za Zhi"},{"key":"9256_CR20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00262-008-0570-x","volume":"58","author":"M Ohara","year":"2009","unstructured":"Ohara M, Yamaguchi Y, Matsuura K et al (2009) Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer. Cancer Immunol Immunother 58:441\u2013447","journal-title":"Cancer Immunol Immunother"},{"key":"9256_CR21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1471-2407-9-231","volume":"9","author":"AS Mansfield","year":"2009","unstructured":"Mansfield AS, Heikkila PS, Vaara AT et al (2009) Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer. BMC Cancer 9:231","journal-title":"BMC Cancer"},{"key":"9256_CR22","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1200\/JCO.2008.17.9036","volume":"27","author":"A Merlo","year":"2009","unstructured":"Merlo A, Casalini P, Carcangiu ML et al (2009) FOXP3 expression and overall survival in breast cancer. J Clin Oncol 27:1746\u20131752","journal-title":"J Clin Oncol"},{"key":"9256_CR23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/02841860701233443","volume":"46","author":"S Gupta","year":"2007","unstructured":"Gupta S, Joshi K, Wig JD, Arora SK (2007) Intratumoral FOXP3 expression in infiltrating breast carcinoma: its association with clinicopathologic parameters and angiogenesis. Acta Oncol 46:792\u2013797","journal-title":"Acta Oncol"},{"key":"9256_CR24","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45","journal-title":"Nucleic Acids Res"},{"key":"9256_CR25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1034\/j.1600-065X.2001.1820104.x","volume":"182","author":"EM Shevach","year":"2001","unstructured":"Shevach EM, McHugh RS, Piccirillo CA et al (2001) Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev 182:58\u201367","journal-title":"Immunol Rev"},{"key":"9256_CR26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/08820130701674463","volume":"36","author":"SP Hilchey","year":"2007","unstructured":"Hilchey SP, Bernstein SH (2007) Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies. Immunol Invest 36:629\u2013648","journal-title":"Immunol Invest"},{"key":"9256_CR27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/08820130701790368","volume":"36","author":"TM Brusko","year":"2007","unstructured":"Brusko TM, Hulme MA, Myhr CB et al (2007) Assessing the in vitro suppressive capacity of regulatory T cells. Immunol Invest 36:607\u2013628","journal-title":"Immunol Invest"},{"key":"9256_CR28","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/10428190802064917","volume":"49","author":"E Capriotti","year":"2008","unstructured":"Capriotti E, Vonderheid EC, Thoburn CJ et al (2008) Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma. Leuk Lymphoma 49:1190\u20131201","journal-title":"Leuk Lymphoma"},{"key":"9256_CR29","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1158\/0008-5472.CAN-06-4296","volume":"67","author":"S Tuve","year":"2007","unstructured":"Tuve S, Chen BM, Liu Y et al (2007) Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses. Cancer Res 67:5929\u20135939","journal-title":"Cancer Res"},{"key":"9256_CR30","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/cncr.21729","volume":"106","author":"K Matsuura","year":"2006","unstructured":"Matsuura K, Yamaguchi Y, Ueno H et al (2006) Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma. Cancer 106:1227\u20131236","journal-title":"Cancer"},{"key":"9256_CR31","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","volume":"24","author":"GJ Bates","year":"2006","unstructured":"Bates GJ, Fox SB, Han C et al (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24:5373\u20135380","journal-title":"J Clin Oncol"},{"key":"9256_CR32","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1073\/pnas.0830997100","volume":"100","author":"FS Hodi","year":"2003","unstructured":"Hodi FS, Mihm MC, Soiffer RJ et al (2003) Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci USA 100:4712\u20134717","journal-title":"Proc Natl Acad Sci USA"},{"key":"9256_CR33","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1073\/pnas.1533209100","volume":"100","author":"GQ Phan","year":"2003","unstructured":"Phan GQ, Yang JC, Sherry RM et al (2003) Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA 100:8372\u20138377","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-010-9256-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-010-9256-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-010-9256-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T07:10:44Z","timestamp":1711350644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-010-9256-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,21]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9256"],"URL":"https:\/\/doi.org\/10.1007\/s12253-010-9256-8","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,21]]}}}